98744948 - BEJOINIQ

Information

• Trademark
• 98744948

• Source

• Serial Number

  98744948

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  September 11, 2024
  11 months ago

• Transaction Date

  July 24, 2025
  14 days ago

• Status Date

  July 16, 2025
  22 days ago

• Published for Opposition Date

  July 29, 2025
  9 days ago

• Location Date

  July 09, 2025
  29 days ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MARTIN, CHRISTINE

• Attorney Docket Number

  00164546-US

  Attorney Name

  Marilyn. F. Kelly

  Law Office Assigned Location Code

  L40

• Owners

  • Celgene Corporation

Case File Statements

• GS0051: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressant preparations, pharmaceutical antibodies for medical use, and immunotherapy preparations for the treatment of cancer; cytokine inhibitory drugs for human use being pharmaceutical preparations for the treatment of cancer; anticoagulants for human use; Pharmaceutical preparations for human use that modulate the immune system for the treatment of immune-system related diseases and disorders; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy preparations for the treatment of cancer; Pharmaceutical and biological preparations for human use, namely, stem cells for medical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use; Pharmaceutical preparations for human use for the treatment of neuropsychiatric disorders; therapeutic radiopharmaceutical preparations for human use for the treatment of cancer and solid tumors; diagnostic radiopharmaceutical preparations for human use; diagnostic preparations for human use for medical purposes; radiopharmaceutical preparations for human use in the nature of imaging and detection agents for diagnosing and monitoring cancer; biological preparations for human use in the nature of radio-isotope markers for therapeutic or diagnostic use; Pharmaceutical preparations for human use for the treatment of cystic fibrosis.

Case File Event Statements

• 9/11/2024 - 11 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 3/21/2025 - 4 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/21/2025 - 4 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 3/21/2025 - 4 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/20/2025 - 4 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/21/2025 - 4 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/23/2025 - a month ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/23/2025 - a month ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/23/2025 - 15 days ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/24/2025 - a month ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/23/2025 - a month ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME